Lineage Cell Therapeutics Inc
ASE:LCTX 3:59:51 PM EDT
Earnings Announcements
Lineage Cell Therapeutics Reports Q1 2022 Results
Published: 05/12/2022 21:10 GMT
Lineage Cell Therapeutics Inc (LCTX) - Lineage Cell Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update.
Qtrly Loss per Share $0.04.
Q1 Earnings per Share View $-0.03 -- Refinitiv Ibes Data (analyst estimates).
Qtrly Loss per Share $0.04.
Q1 Earnings per Share View $-0.03 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $3.7 Million
Adjusted EPS is expected to be -$0.03
Next Quarter Revenue Guidance is expected to be $3.68 Million
Next Quarter EPS Guidance is expected to be -$0.04
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.03
Next Quarter Revenue Guidance is expected to be $3.68 Million
Next Quarter EPS Guidance is expected to be -$0.04
More details on our Analysts Page.